Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #136 on Amylyx Pharmaceuticals Inc (AMLX)
Whalatane
10/16/25 11:38 AM
#137 RE: ErnieBilco #136
Baird analyst Joel Beatty maintains Amylyx Pharmaceuticals (AMLX.NaE) with a Outperform and raises the price target from $10 to $19.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads